Issuance of Stock Acquisition Rights
First written in FY2017-Q2. 17 of 19 entries say "Advanced", first in FY2017. Latest entry: 2026-09-10.
The whole theme swung hardest in 2026: 1 of 9 companies on the "Worse" side.
3 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「37th Series stock acquisition rights (Number of stock acquisition rights: 3,600 units) 38th Series stock acquisition rights (Number of stock acquisition rights: 1,500 units)」
The 37th and 38th Series stock acquisition rights were issued. They cover a total of 510,000 shares, with an exercise price of ¥1,897 and an exercise period from 12 September 2027 to 31 March 2031. - FY2025-H1AdvancedAnnual report
「35th Series stock acquisition rights (Number of stock acquisition rights: 3,150 units) 36th Series stock acquisition rights (Number of stock acquisition rights: 1,500 units)」
Based on resolutions dated 25 June and 27 August 2024, the 35th and 36th Series stock acquisition rights were issued. They cover a total of 465,000 shares, with an exercise price of ¥1,539 and an exercise period from 12 September 2026 to 31 March 2030. - FY2024-Q2AdvancedAnnual report
「33rd Series stock acquisition rights (Number of stock acquisition rights: 3,000 units) 34th Series stock acquisition rights (Number of stock acquisition rights: 1,500 units)」
The 33rd and 34th Series stock acquisition rights, approved on 22 August 2023 and issued on 6 September, were added. They cover a total of 450,000 shares, with an exercise price of ¥1,405 and an exercise period from 7 September 2025 to 31 March 2029. - FY2023AdvancedAnnual report
「Decrease due to the exercise of stock acquisition rights 335,000 shares」
While 335,000 treasury shares were disposed of through the exercise of existing stock options, the 31st and 32nd Series stock acquisition rights, covering a combined 500,000 shares, remain outstanding. - FY2023-Q2AdvancedAnnual report
「Overview of potential shares that were not included in the calculation of diluted quarterly net income per share because they had no dilutive effect, but that had undergone material changes from the end of the previous consolidated fiscal year: 29th Series stock acquisition rights (3,100 units); 30th Series stock acquisition rights (1,650 units); 31st Series stock acquisition rights (3,350 units); 32nd Series stock acquisition rights (1,650 units).」
In addition to the existing 29th and 30th Series, the 31st Series (3,350 units) and 32nd Series (1,650 units) stock acquisition rights were listed as potential shares with material changes. - FY2022-Q3AdvancedAnnual report
「Overview of potential shares that were not included in the calculation of diluted quarterly net income per share because they had no dilutive effect, but that had undergone material changes from the end of the previous consolidated fiscal year - 29th Series stock acquisition rights (Number of stock acquisition rights: 3,100 units) 30th Series stock acquisition rights (Number of stock acquisition rights: 1,650 units)」
The 29th Series (3,100 units) and 30th Series (1,650 units) stock acquisition rights are listed as potential shares that underwent material changes from the end of the previous consolidated fiscal year. - FY2021-Q2AdvancedAnnual report
「Resolution date 24 June 2020; number of stock acquisition rights (units) 1,560; class, description and number of shares underlying the stock acquisition rights (shares): ordinary shares 156,000; payment amount upon exercise (yen) 910; exercise period 11 September 2022 to 31 March 2026. Resolution date 26 August 2020; number of stock acquisition rights (units) 3,050; class, description and number of shares underlying the stock acquisition rights (shares): ordinary shares 305,000; payment amount upon exercise (yen) 910; exercise period 11 September 2022 to 31 March 2026.」
The 27th and 28th Series stock acquisition rights were issued, totaling 4,610 units and covering 461,000 shares, with an exercise price of ¥910 and an exercise period from 11 September 2022 to 31 March 2026. - FY2020-Q2AdvancedAnnual report
「For the stock acquisition rights approved on 25 June 2019: 1,510 rights, covering 151,000 shares, with a payment amount upon exercise of ¥759 and an exercise period from 12 September 2021 to 31 March 2025. For the stock acquisition rights approved on 27 August 2019: 3,050 rights, covering 305,000 shares, with a payment amount upon exercise of ¥759 and an exercise period from 12 September 2021 to 31 March 2025.」
The 25th and 26th Series stock acquisition rights were issued, totaling 4,560 units and covering 456,000 shares, with an exercise price of ¥759 and an exercise period from 12 September 2021 to 31 March 2025. - FY2019-Q2AdvancedAnnual report
「On 26 June 2018: 1,220 stock acquisition rights, covering 122,000 shares, with a payment amount upon exercise of ¥962 and an exercise period from 13 September 2020 to 31 March 2024. On 28 August 2018: 3,650 stock acquisition rights, covering 365,000 shares, with a payment amount upon exercise of ¥962 and an exercise period from 13 September 2020 to 31 March 2024.」
The 23rd and 24th Series stock acquisition rights were issued, totaling 4,870 units and covering 487,000 shares, with an exercise price of ¥962. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter are as follows. 21st Series (special resolution at the general meeting of shareholders held on 27 June 2017): Number of stock acquisition rights (units) 1,270; number of shares underlying the stock acquisition rights (shares) 127,000; payment amount upon exercise (yen) 1,056; exercise period 13 September 2019 to 31 March 2023. 22nd Series (resolution of the Board of Directors dated 28 August 2017): Number of stock acquisition rights (units) 3,300; number of shares underlying the stock acquisition rights (shares) 330,000; payment amount upon exercise (yen) 1,056; exercise period 13 September 2019 to 31 March 2023.」
The 21st and 22nd Series stock acquisition rights were issued, totaling 4,570 units and covering 457,000 shares, with an exercise price of ¥1,056. - FY2017AdvancedAnnual report
「For the 21st Series stock acquisition rights (resolution at the annual general meeting of shareholders held on 27 June 2017), the eligible recipients will be determined by a resolution of the Board of Directors to be held after the filing date of this annual securities report. The maximum number of shares is 190,000. Exercise period: the day following the second anniversary of the allotment date to 31 March 2023.」
For the 21st Series stock acquisition rights, the eligible recipients will be determined by a future resolution of the Board of Directors, with an additional grant allocation capped at 190,000 shares. - FY2017-Q2First statedAnnual report
「19th Series (special resolution at the general meeting of shareholders held on 28 June 2016): Number of stock acquisition rights (units) 1,260; number of shares underlying the stock acquisition rights (shares) 126,000; payment amount upon exercise (yen) 702; exercise period 13 September 2018 to 31 March 2022. 20th Series (resolution of the Board of Directors dated 26 August 2016): Number of stock acquisition rights (units) 3,650; number of shares underlying the stock acquisition rights (shares) 365,000; payment amount upon exercise (yen) 702; exercise period 13 September 2018 to 31 March 2022.」
A total of 4,910 19th and 20th Series stock acquisition rights were issued, covering a total of 491,000 shares, with an exercise price of ¥702 and an exercise period from 13 September 2018 to 31 March 2022.